S
Sanofi Portfolio holdings
AUM
$176M
This Quarter Return
+1%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$174M
AUM Growth
–
Cap. Flow
+$174M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
MeiraGTx Holdings
MGTX
|
$74.3M |
| 2 |
Novavax
NVAX
|
$55.3M |
| 3 |
Inhibrx
INBX
|
$17.8M |
| 4 |
AnaptysBio
ANAB
|
$10.9M |
| 5 |
IGMS
IGM Biosciences
IGMS
|
$8.79M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
MeiraGTx Holdings
MGTX
$587M
| $74.3M | 42.6% |
+12,197,737
| New | +$74.3M |
|
|
2
Novavax
NVAX
$1.23B
| $55.3M | 31.73% |
+6,880,481
| New | +$55.3M |
|
|
3
Inhibrx
INBX
$404M
| $17.8M | 10.23% |
+1,157,926
| New | +$17.8M |
|
|
4
AnaptysBio
ANAB
$580M
| $10.9M | 6.24% |
+821,917
| New | +$10.9M |
|
|
IGMS
5
DELISTED
IGM Biosciences
IGMS
| $8.79M | 5.04% |
+1,438,975
| New | +$8.79M |
|
6
Eledon Pharmaceuticals
ELDN
$153M
| $3.36M | 1.93% |
+814,980
| New | +$3.36M |
|
7
LAVA Therapeutics
LVTX
$41M
| $1.83M | 1.05% |
+1,919,455
| New | +$1.83M |
|
|
INZY
8
DELISTED
Inozyme Pharma
INZY
| $1.23M | 0.7% |
+443,255
| New | +$1.23M |
|
9
Q32 Bio
QTTB
$21.2M
| $840K | 0.48% |
+244,083
| New | +$840K |
|